Robert F. Apple - 18 Mar 2026 Form 3 Insider Report for KAZIA THERAPEUTICS LTD (KZIA)

Role
Director
Signature
/s/ Jeffrey Bonacorda, Attorney-in-Fact
Issuer symbol
KZIA
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 17:47:31 UTC
Previous filing
26 May 2022
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
APPLE ROBERT F Director THREE INTERNATIONAL TOWERS, LEVEL 24, 300 BARANGAROO AVE, SYDNEY, NSW, AUSTRALIA /s/ Jeffrey Bonacorda, Attorney-in-Fact 18 Mar 2026 0001054942

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KZIA American Depositary Share Option (Right to Buy) 18 Mar 2026 American Depositary Shares 2,000 $0.3348 Direct F1, F2
holding KZIA American Depositary Share Option (Right to Buy) 18 Mar 2026 American Depositary Shares 75,000 $6.58 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The American Depositary Shares ("ADSs") subject to the option ("ADS option") vest in equal quarterly installments over three years beginning on April 30, 2024, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The ADS option was granted on April 30, 2024.
F2 Each ADS option is convertible into ADSs upon exercise. Each ADS may be represented by 500 ordinary shares of the Issuer, no par per share (the "Ordinary Shares"), at any time, upon the holder's election to surrender the ADSs and withdraw the respective number of Ordinary Shares. The ADSs have no expiration date.
F3 The ADSs subject to the ADS option vest in three equal annual installments beginning on July 3, 2025, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The ADS option was granted on July 3, 2025.

Remarks:

Exhibit 24 - Power of Attorney